Bikam Pharmaceuticals is Pharmaceuticals in United States that focus on pharmacological chaperones focuse business. Founded in 2007. They cover business area such as developer, novel therapeutic, retinal degenerative disease, treatment, retinitis pigmentosa, blindness, an orally active pharmacological chaperone, rod opsin, rp, its trafficking, cell surface, outer segment.
2007
( 17 years old in 2024 )
Pharmacological Chaperones Focuse
-
55 Cambridge Parkway
Suite 301
Cambridge, MA 02142
United States
Private
developernovel therapeuticretinal degenerative diseasetreatmentretinitis pigmentosablindnessan orally active pharmacological chaperonerod opsinrpits traffickingcell surfaceouter segment
* We use standard office opening hours in near Bikam Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bikam Pharmaceuticals is Pharmaceuticals business from United States that founded in 2007 (17 years old in 2024), Bikam Pharmaceuticals business is focusing on Pharmacological Chaperones Focuse.
Bikam Pharmaceuticals headquarter office and corporate office address is located in 55 Cambridge Parkway Suite 301 Cambridge, MA 02142 United States.
Bikam Pharmaceuticals was founded in United States.
In 2024, Bikam Pharmaceuticals is currently focus on pharmacological chaperones focuse sector.
Above is snippet of Google Trends for "pharmacological chaperones focuse" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bikam Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
